AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
iRhythm Holdings, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001TSQV70
121.27▲ 1.63 (1.36%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
119.64
Day's Range
117.67 – 122.50
52-Week Range
100.70 – 212.00
Volume
456.5K
Avg Volume
496.0K
Share Statistics
Shares Outstanding
Employees
2,400
Exchange
XNAS
Listed
2016-10-20
Share count as of July 30, 2026

iRhythm Holdings, Inc. Common Stock (IRTC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about iRhythm Holdings, Inc. Common Stock (IRTC)
What is iRhythm Holdings, Inc. Common Stock's Market Cap?
iRhythm Holdings, Inc. Common Stock's Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's Price / Sales?
iRhythm Holdings, Inc. Common Stock's Price / Sales is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's Revenue (TTM)?
iRhythm Holdings, Inc. Common Stock's Revenue (TTM) is $825.3M, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's Net Income (TTM)?
iRhythm Holdings, Inc. Common Stock's Net Income (TTM) is -$13.9M, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's EBITDA?
iRhythm Holdings, Inc. Common Stock's EBITDA is -$4.2M, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's Diluted EPS (TTM)?
iRhythm Holdings, Inc. Common Stock's Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.
What is iRhythm Holdings, Inc. Common Stock's EBITDA Margin?
iRhythm Holdings, Inc. Common Stock's EBITDA Margin is -0.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IRTCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue, net
YoY growth+20.1%+25.7%+27.1%+30.7%
Cost of revenue
Gross profit
% of revenue72.8%70.9%70.9%71.1%
Operating expenses:
Research and development
Acquired in-process research and development
Selling, general and administrative
Litigation settlements———
Impairment charges—
Total operating expenses
% of revenue73.9%79.0%69.8%75.5%
Loss from operations
% of revenue-1.1%-8.1%1.1%-4.4%
Interest and other income, net:
Interest income
Interest expense
Other income, net
Total interest and other income, net
Loss before income taxes
Income tax provision (benefit)
Net loss
% of revenue-0.2%-7.0%2.7%-2.7%
Net loss per common share, basic (in USD per share)
Net loss per common share, diluted (in USD per share)